Pancreatitis
severe·rare
Side effects
Side-effect profile resembles Semaglutide but with slightly higher nausea and diarrhea rates due to added GIP (hormone that improves insulin sensitivity) activation. SURMOUNT-1 reports transient gastrointestinal signal in 60-70% of participants during the first 12 weeks.
Sorted by severity. Source cited when published.
Pancreatitis
severe·rare
Nausea
moderate·common·SURMOUNT-1
Diarrhea
moderate·common·SURMOUNT-1
Vomiting
moderate·common
Constipation
mild·common
Injection-site reaction
mild·uncommon
Family history of MTC or MEN-2.
Dosing
Tirzepatide dosing protocol
Encyclopedia
Full scientific profile for Tirzepatide
Disclaimer: data is curated from research literature for in-vitro experiments. This is not medical advice.